Uninsured South Florida vascular surgery patients are less likely to receive optimal medical management than their insured counterparts

Journal of Vascular Surgery

Volumn 51, Issue 4 SUPPL., 2010, Pages

  Yeh, Dante ^a   Jones, Monique ^a   Schulman, Carl ^a   Karmacharya, Jagajan ^a   Velazquez, Omaida C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; CHRONIC KIDNEY FAILURE; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH INSURANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POSTOPERATIVE CARE; PREDICTION; PRIORITY JOURNAL; SELF REPORT; SMOKING; VASCULAR SURGERY;

ACADEMIC MEDICAL CENTERS; AGED; CARDIOVASCULAR AGENTS; COMORBIDITY; ETHNIC GROUPS; FEMALE; FLORIDA; GUIDELINE ADHERENCE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH; MALE; MEDICALLY UNINSURED; MIDDLE AGED; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 77949582657     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2010.01.035     Document Type: Article

References (40)

1. National Center for Health Statistics, Centers for Disease Control and Prevention. Compressed mortality file: underlying cause of death, 1979 to 2004. http://wonder.cdc.gov/cmf-icd10-archive2004.html http://wonder.cdc.gov/cmf-icd10-archive2004.html.
2. Centers for Medicare and Medicaid Services. Health care financing review: Medicare and Medicaid Statistical Supplement. http://www.cms.hhs.gov/MedicareMedicaidStatSupp/LT/list.asp?intNumPerPag e=all&submit=Go
3. Feinglass J., Pearce W.H., Martin G.F., Gibbs J., Cowper D., Sorensen M., et al. Postoperative and amputation-free survival outcomes after femorodistal bypass grafting surgery: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program. J Vasc Surg 34 (2001) 283-290
4. Bainton D., Sainton P., Baker I., and Elwood P. Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study. Br Heart J 72 (1994) 128-132
5. Timsit S.G., Sacco R.L., Mohr J.P., Foulkes M.A., Tatemichi T.K., Wolf P.A., et al. Early clinical differentiation of cerebral infarction from severe atherosclerotic stenosis and cardioembolism. Stroke 23 (1992) 486-491
6. Antiplatelet Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 524 (2002) 71-86
7. Pederson T., Kjekshus J., Berg K., Haghfelt T., Faergeman O., Faergeman G., et al. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344 (1994) 1383-1389
8. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000) 45-53
9. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
10. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Lancet 355 (2000) 1955-1964
11. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
12. Durazzo A.E., Machado F.S., Ikeoka D.T., De Bernoche C., Monachini M.C., Puech-Leao P., et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 39 (2004) 967-976
13. Pederson T.R., Kjekshus J., Pyörälä K., Olsson A.G., Cook T.J., Musliner T.A., et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Study (4S). Am J Cardiol 81 (1998) 333-335
14. Mondillo S., Ballo P., Barbati R., Guerrini F., Ammaturo T., Agricola E., et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114 (2003) 359-364
15. Henke P.K., Blackburn S., Proctor M.C., Stevens J., Mukherjee D., Rajagopalin S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: Effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004) 357-365
16. Lehto S., Rönnemaa T., Pyörälä K., and Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27 (1996) 63-68
17. Wolf P.A., D'Agostino R.B., Kannel W.B., Bonita R., and Belanger A.J. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA 259 (1988) 1025-1029
18. Smith S.C., Blair S.N., Bonow R.O., Brass L.M., Cerqueira M.D., Dracup K., et al. AHA/ACC scientific statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation 104 (2001) 1577-1579
19. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
20. Smith S.C., Allen J., Blair S.N., Bonow R.O., Brass L.M., Fonarow G.C., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 113 (2006) 2363-2372
21. Kinikini D., Sarfati M.R., Mueller M.T., and Kraiss L.W. Meeting AHA/ACC secondary prevention goals in a vascular surgery practice: an opportunity we cannot afford to miss. J Vasc Surg 339 (2006) 781-787
22. Berlowitz D.R., Ash A.S., Hickey E.C., Friedman R.H., Glickman M., Kader B., et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 339 (1998) 1957-1963
23. Betancourt M., Van Stavern R.B., Share D., Gardella P., Martus M., and Chaturvedi S. Are patients receiving maximal medical therapy following carotid endarterectomy?. Neurology 63 (2004) 2011-2015
24. Mukherjee D., Lingam P., Chetcuti S., Grossman P.M., Moscucci M., Luciano A.E., et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions. Circulation 106 (2002) 1909-1912
25. McDermott M.M., Mehta S., Ahn H., and Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12 (1997) 209-215
26. Burns P., Lima E., and Bradbury A.W. Second best medical therapy. Eur J Vasc Endovasc Surg 24 (2002) 400-404
27. Rehring T.F., Sandhoff B.G., Stolcpart R.S., Merenich J.A., and Hollis H.W. Atherosclerotic risk factor control in patients with peripheral arterial disease. J Vasc Surg 41 (2005) 816-822
28. Cassar K., Coull R., Bachoo P., Macaulay E., and Brittenden J. Management of secondary risk factors in patients with intermittent claudication. Eur J Vasc Endovasc Surg 26 (2003) 262-266
29. Ness J., Aronow W.S., Newkirk E., and McDanel D. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic. J Gerontol 60A (2005) 255-257
30. Bismuth J., Klitfod, and Sillesen H. The lack of cardiovascular risk factor management in patients with critical limb ischemia. Eur J Vasc Endovasc Surg 21 (2001) 143-146
31. Stockwell D.H., Madhavan S., Cohen H., Gibson G., and Alderman M.H. The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 84 (1994) 1768-1774
32. Hughes J.R., Stead L.F., and Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev (2007) CD000031
33. Law M., and Tang J.L. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 155 (1995) 1933-1941
34. Rask K.J., Williams M.V., Parker R.M., and McNagny S.E. Obstacles predicting lack of a regular provider and delays in seeking care for patients at an urban public hospital. JAMA 271 (1994) 1931-1933
35. Ahluwalia J.S., McNagny S.E., and Rask K.J. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med 12 (1997) 7-14
36. Shulman N.B., Martinez B., Brogan D., Carr A.A., and Miles C.D. Financial cost as an obstacle to hypertnesion therapy. Am J Public Health 76 (1986) 1105-1108
37. González-Fernández R.A., Rivera M., Torres D., Quiles J., and Jackson A. Usefulness of a systemic hypertension in-hospital education program. Am J Cardiol 65 (1990) 1384-1386
38. Farquhar J.W., Fortmann S.P., Flora J.A., Taylor C.B., Haskell W.L., William P.T., et al. Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA 264 (1990) 359-365
39. Brook R.H., Ware Jr. J.E., Rogers W.H., Keeler E.B., Davies A.R., Donald C.A., et al. Does free care improve adults' health?. Results from a randomized controlled trial. N Engl J Med 309 (1983) 1426-1434
40. Keeler E.B., Brook R.H., Goldberg G.A., Kamberg C.J., and Newhouse J.P. How free care reduced hypertension in the health insurance experiment. JAMA 254 (1985) 1926-1931